Preformulation studies of a prodrug of Δ9 -Tetrahydrocannabinol

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 982-990

  Thumma, Sridhar ^a   Majumdar, Soumyajit ^a,b   ElSohly, Mahmoud A ^a,b,c   Gul, Waseem ^b,c   Repka, Michael A ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c ElSohly Laboratories Incorporated   (United States)

Author keywords

Molecular weight; PEO; Preformulation; Solubility; Stability; THC

Indexed keywords

DRONABINOL; GLUTARIC ACID; MACROGOL; OXYGEN; PLACEBO; POLYMER; PRODRUG;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG RELEASE; DRUG RESEARCH; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH TEMPERATURE PROCEDURES; HUMIDITY; MOISTURE; MOLECULAR WEIGHT; PH; PKA; PREFORMULATION; SOLID STATE; TEMPERATURE SENSITIVITY; THERMOGRAVIMETRY;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; HUMIDITY; HYDROGEN-ION CONCENTRATION; PRODRUGS; SOLUBILITY; TEMPERATURE; TETRAHYDROCANNABINOL;

EID: 57149137189     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9136-7     Document Type: Article

References (25)

1. E. A. Voth, and R. H. Schwartz. Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann. Intern. Med. 126: 791-798 (1997).
2. A. Ohlsson, J. E. Lindgren, A. Wahlen, et al. Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin. Pharmacol. Ther. 28: 409-416 (1980).
3. R. Mechoulam. Marihuana chemistry. Science. 168: 1159-1166 (1970).
4. J. W. Fairbairn, J. A. Liebmann, and M. G. Rowan. The stability of cannabis and its preparations on storage. J. Pharm. Pharmacol. 28: 1-7 (1976).
5. R. Mechoulam, and L. Hanus. A historical overview of chemical research on cannabinoids. Chem. Phys. Lipids. 108: 1-13 (2000).
6. M. A. ElSohly, S. A. Ross, and S. Feng. Method of preparing delta-9-tetrahydrocannabinol esters. In: US patent 6008383; 1999
7. L. Lachman, H. A. Lieberman, and J. L. Kanig. The theory and practice of industrial pharmacy, Lea & Febiger, Philadelphia, 1986.
8. M. Munjal, M. A. ElSohly, and M. A. Repka. Chemical stabilization of a delta-9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: Role of microenvironment pH. AAPS PharmSciTech. 7: 71 (2006).
9. F. Zhang, and J. W. McGinity. Properties of sustained-release tablets prepared by hot-melt extrusion. Pharm. Dev. Technol. 4: 241-250 (1999).
10. M. A. Repka, and J. W. McGinity. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int. J. Pharm. 202: 63-70 (2000).
11. M. A. Repka, K. Gutta, S. Prodduturi, M. Munjal, and S. P. Stodghill. Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur. J. Pharm. Biopharm. 59: 189-196 (2005).
12. M. A. Repka, T. G. Gerding, S. L. Repka, and J. W. McGinity. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot-melt extrusion. Drug Dev. Ind. Pharm. 25: 625-633 (1999).
13. S. Prodduturi, R. V. Manek, W. M. Kolling, S. P. Stodghill, and M. A. Repka. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J. Pharm. Sci. 94: 2232-2245 (2005).
14. E. R. Garrett, and C. A. Hunt. Physiochemical properties, solubility, and protein binding of delta 9-tetrahydrocannabinol. J. Pharm. Sci. 63: 1056-1064 (1974).
15. M. A. Repka, and J. W. McGinity. Physical-mechanical, moisture absorption and bioadhesive properties of hydroxypropylcellulose hot-melt extruded films. Biomaterials. 21: 1509-1517 (2000).
16. M. A. Repka, and J. W. McGinity. Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J. Control. Release. 70: 341-351 (2001).
17. M. Kopcha, K. J. Tojo, and N.G. Lordi. Evaluation of methodology for assessing release characteristics of thermosoftening vehicles. J. Pharm. Pharmacol. 42: 745-751 (1990).
18. N. A. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60: 110-111 (1985).
19. A. Martin. Physical Pharmacy, 4th ed., Lea & Febiger, Philadelphia, 1993.
20. N. Ni, T. Sanghvi, and S. H. Yalkowsky. Stabilization and preformulation of anticancer drug - SarCNU. Int. J. Pharm. 249: 257-264 (2002).
21. J. Drustrup, A. Fullerton, L. Christrup, and H. Bundgaard. Utilization of prodrugs to enhance the transdermal absorption of morphine. Int. J. Pharm. 71: 105-116 (1991).
22. S. Yoshioka, and J. T. Carstensen. Nonlinear estimation of kinetic parameters for solid-state hydrolysis of water-soluble drugs. II: Rational presentation mode below the critical moisture content. J. Pharm. Sci. 79: 799-801 (1990).
23. C. Ahlneck, and G. Zografi. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm. 62: 87-95 (1990).
24. K. A. Connors, G. L. Amidon, and V. J. Stella. Chemical Stability of Pharmaceuticals: A handbook for pharmacists, 2nd ed., Wiley, New York, 1986.
25. D. Duchene, F. Touchard, and N. A. Peppas. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharm. 14: 283-318 (1988).